Project Grant R01AG081655
Award Date
7/15/24
Completion Date
3/31/29
Dollars Obligated
$2.4M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
The National Institute on Aging (NIA) awarded a $630,496 Project Grant under the Aging Research program (CFDA 93.866) to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, CA. The 5-year grant, awarded on June 1, 2025, supports research to investigate the underlying mechanisms of proteostasis dysfunction and neuroinflammation in frontotemporal dementia (FTD) caused by granulin (GRN) deficiency. The research aims to better define alterations in...
The federal Project Grant award K23AG088248, valued at $198,355.00, was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The purpose of this 5-year award is to enhance understanding of the neurobiology of neuropsychiatric symptoms (NPS) in behavioral variant frontotemporal dementia (bvFTD) in order to inform the development of novel, precision-targeted therapies. The study will utilize positron emission tomography (PET) to measure...
This federal Project Grant award, funded by the National Institute on Aging (CFDA 93.866 - Aging Research), supports research to improve understanding of frontotemporal lobar degeneration (FTLD), a group of neurodegenerative disorders. The total award amount is $1,076,760.00 and the performance period runs from September 30, 2024 to August 31, 2029. The key objectives of this grant are to: 1) Generate a humanized FTLD-TDP mouse model by transplanting patient-derived microglia into mice...
This Project Grant award, with a total funding amount of $208,750, was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The project aims to characterize autonomic impairments in patients with the behavioral variant of frontotemporal dementia (bvFTD) using novel wearable technologies. Specifically, the grant will first assess the reliability of "gold-standard" laboratory measurements of autonomic function in bvFTD patients...
This $805,790 Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) supports a 5-year study to develop multi-analyte algorithms for screening and prognosis of frontotemporal lobar degeneration (FTLD), a neurodegenerative proteinopathy. The study leverages an autopsy-confirmed FTLD cohort at the University of Pennsylvania to pathologically validate biomarkers of neurodegeneration, neuroinflammation, and synaptic dysfunction in FTLD subtypes. It aims to map the...
The National Institute on Aging (NIA), part of the Department of Health and Human Services National Institutes of Health, awarded a $3.37 million Project Grant to The University of Texas at Arlington to develop an individualized deep connectome framework for Alzheimer's disease and related dementias (ADRD) analysis. The three-year grant, awarded on August 18, 2022 under the NIA's Aging Research program (CFDA 93.866), will support research to discover and identify individualized...
This Project Grant award from the National Institute on Aging under CFDA 93.866 "Aging Research" provides $716,919 to the University of Southern California to conduct research aimed at understanding the neural mechanisms underlying neuropsychiatric symptoms associated with Alzheimer's disease. The project will integrate behavioral assessments, spatial transcriptomics, anatomy, pathology, and neural function analysis in mouse models of Alzheimer's to explore cortical pathological...
This $459,525 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports Aperture Therapeutics, Inc. in rapidly discovering a novel oligonucleotide therapeutic for direct modulation of a genetically validated target involved in pathologic neuroinflammation. The project aims to leverage Aperture's high-throughput iPSC platform with diverse genetic models of frontotemporal dementia (FTD) to provide robust functional evidence for further development...
This $419,375 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the role of neuron-specific genes NSG1 and NSG2 in regulating the sortilin-1 (SORT1) protein and its potential implications for Alzheimer's disease (AD) and frontotemporal dementia (FTD). The project will utilize post-mortem human and rodent brain samples to correlate NSG1-2 expression levels with AD/FTD disease subtypes and SORT1 proteolytic processing. It will then employ...
This $224,140 Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) supports research to elucidate the mechanisms of circuit dysfunction in frontotemporal dementia (FTD) caused by the C9ORF72 gene mutation. The research aims to monitor the progression of neuronal activity and its relationship to neuronal loss, as well as determine whether neuronal hyperactivity can drive the progression of FTD pathology and behavioral deficits. The award recipient, The General...